FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312933497> ?p ?o ?g. }

• W2312933497 endingPage "868" @default.
• W2312933497 startingPage "859" @default.
• W2312933497 abstract "Changes in glucose metabolism during diabetes are linked to an increased risk for the development of cancer. Increased activity of aldose reductase, the rate-limiting polyol pathway enzyme that converts glucose into sorbitol, mediates pathologies associated with diabetes and is thought to be involved in increased resistance to chemotherapeutic drugs. Thus, increased intracellular sorbitol levels may serve a protective function in cancer cells. In these studies we determined whether an inhibitor of aldose reductase could enhance the effectiveness of anticancer agents. Our findings indicate that treatment with the aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate (EBPC), enhances the cytotoxic effects of the anticancer agents doxorubicin and cisplatin in HeLa cervical carcinoma cells. To establish a mechanistic basis for the increased cytotoxicity by EBPC, we examined the activity of the extracellular signal-regulated kinase (ERK) pathway, which is an important regulator of cell growth. Interestingly, treatment with EBPC in combination with the chemotherapeutic drugs increased ERK activity as compared to treatment with the chemotherapeutic drugs, suggesting a possible role for the ERK pathway in mediating doxorubicin- or cisplatin-induced cell death. Consistent with this possibility, inhibition of ERK activation by the MEK inhibitor, U0126, reversed the EBPC-mediated enhancement of cell death. In summary, these data provide evidence that adjuvant therapy with aldose reductase inhibitors improves the effectiveness of chemotherapeutic drugs, possibly through an ERK pathway-mediated mechanism." @default.
• W2312933497 created "2016-06-24" @default.
• W2312933497 creator A5002904226 @default.
• W2312933497 creator A5014227217 @default.
• W2312933497 creator A5028121551 @default.
• W2312933497 date "2002-09-01" @default.
• W2312933497 modified "2023-09-24" @default.
• W2312933497 title "Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases" @default.
• W2312933497 cites W1566737177 @default.
• W2312933497 cites W1965283399 @default.
• W2312933497 cites W1966851408 @default.
• W2312933497 cites W1967159904 @default.
• W2312933497 cites W1980786588 @default.
• W2312933497 cites W1980960629 @default.
• W2312933497 cites W1983754683 @default.
• W2312933497 cites W1983810785 @default.
• W2312933497 cites W1988367009 @default.
• W2312933497 cites W1993454824 @default.
• W2312933497 cites W1996213262 @default.
• W2312933497 cites W1998118806 @default.
• W2312933497 cites W2002989747 @default.
• W2312933497 cites W2008889671 @default.
• W2312933497 cites W2012373895 @default.
• W2312933497 cites W2021736277 @default.
• W2312933497 cites W2024559611 @default.
• W2312933497 cites W2027259499 @default.
• W2312933497 cites W2048748542 @default.
• W2312933497 cites W2061971979 @default.
• W2312933497 cites W2066171855 @default.
• W2312933497 cites W2067915181 @default.
• W2312933497 cites W2079141774 @default.
• W2312933497 cites W2082107454 @default.
• W2312933497 cites W2084258035 @default.
• W2312933497 cites W2086989377 @default.
• W2312933497 cites W2120312887 @default.
• W2312933497 cites W2143347137 @default.
• W2312933497 cites W2146838679 @default.
• W2312933497 cites W2161779132 @default.
• W2312933497 cites W2278105335 @default.
• W2312933497 cites W2283603098 @default.
• W2312933497 cites W2319257648 @default.
• W2312933497 cites W3024129737 @default.
• W2312933497 doi "https://doi.org/10.1097/00001813-200209000-00012" @default.
• W2312933497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12394272" @default.
• W2312933497 hasPublicationYear "2002" @default.
• W2312933497 type Work @default.
• W2312933497 sameAs 2312933497 @default.
• W2312933497 citedByCount "37" @default.
• W2312933497 countsByYear W23129334972012 @default.
• W2312933497 countsByYear W23129334972014 @default.
• W2312933497 countsByYear W23129334972015 @default.
• W2312933497 countsByYear W23129334972016 @default.
• W2312933497 countsByYear W23129334972017 @default.
• W2312933497 countsByYear W23129334972019 @default.
• W2312933497 countsByYear W23129334972020 @default.
• W2312933497 countsByYear W23129334972021 @default.
• W2312933497 crossrefType "journal-article" @default.
• W2312933497 hasAuthorship W2312933497A5002904226 @default.
• W2312933497 hasAuthorship W2312933497A5014227217 @default.
• W2312933497 hasAuthorship W2312933497A5028121551 @default.
• W2312933497 hasConcept C121608353 @default.
• W2312933497 hasConcept C126322002 @default.
• W2312933497 hasConcept C136502266 @default.
• W2312933497 hasConcept C1491633281 @default.
• W2312933497 hasConcept C181199279 @default.
• W2312933497 hasConcept C184235292 @default.
• W2312933497 hasConcept C185592680 @default.
• W2312933497 hasConcept C2776439734 @default.
• W2312933497 hasConcept C2776694085 @default.
• W2312933497 hasConcept C2777366897 @default.
• W2312933497 hasConcept C2777374081 @default.
• W2312933497 hasConcept C2778239845 @default.
• W2312933497 hasConcept C28406088 @default.
• W2312933497 hasConcept C502942594 @default.
• W2312933497 hasConcept C55493867 @default.
• W2312933497 hasConcept C57074206 @default.
• W2312933497 hasConcept C62112901 @default.
• W2312933497 hasConcept C62478195 @default.
• W2312933497 hasConcept C71924100 @default.
• W2312933497 hasConcept C86803240 @default.
• W2312933497 hasConcept C96232424 @default.
• W2312933497 hasConcept C98274493 @default.
• W2312933497 hasConceptScore W2312933497C121608353 @default.
• W2312933497 hasConceptScore W2312933497C126322002 @default.
• W2312933497 hasConceptScore W2312933497C136502266 @default.
• W2312933497 hasConceptScore W2312933497C1491633281 @default.
• W2312933497 hasConceptScore W2312933497C181199279 @default.
• W2312933497 hasConceptScore W2312933497C184235292 @default.
• W2312933497 hasConceptScore W2312933497C185592680 @default.
• W2312933497 hasConceptScore W2312933497C2776439734 @default.
• W2312933497 hasConceptScore W2312933497C2776694085 @default.
• W2312933497 hasConceptScore W2312933497C2777366897 @default.
• W2312933497 hasConceptScore W2312933497C2777374081 @default.
• W2312933497 hasConceptScore W2312933497C2778239845 @default.
• W2312933497 hasConceptScore W2312933497C28406088 @default.
• W2312933497 hasConceptScore W2312933497C502942594 @default.
• W2312933497 hasConceptScore W2312933497C55493867 @default.
• W2312933497 hasConceptScore W2312933497C57074206 @default.

• next